top of page

Tarsus' CEO on the launch XDEMVY and additional programs that will be reading out in 2024

Bobby Azamian provides an update on the commercial launch of XDEMVY in Demodex blepharitis, and discusses programs for Meibomian Gland Disease, rosacea, and Lyme disease.

Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page